Literature DB >> 19716299

Identification of methysticin as a potent and non-toxic NF-kappaB inhibitor from kava, potentially responsible for kava's chemopreventive activity.

Ahmad Ali Shaik1, David Lee Hermanson, Chengguo Xing.   

Abstract

Nuclear factor-kappaB (NF-kappaB) is a transcription factor that plays an essential role in cancer development. The results of our recent chemopreventive study demonstrate that kava, a beverage in the South Pacific Islands, suppresses NF-kappaB activation in lung adenoma tissues, potentially a mechanism responsible for kava's chemopreventive activity. Methysticin is identified as a potent NF-kappaB inhibitor in kava with minimum toxicity. Other kava constituents, including four kavalactones of similar structures to methysticin, demonstrate minimum activities in inhibiting NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716299      PMCID: PMC2756981          DOI: 10.1016/j.bmcl.2009.08.003

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  36 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

Review 2.  NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.

Authors:  Laurence J Egan; Murat Toruner
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

3.  Determination of kava lactones in food supplements by liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry.

Authors:  I Bobeldijk; G Boonzaaijer; E J Spies-Faber; W H J Vaes
Journal:  J Chromatogr A       Date:  2005-03-04       Impact factor: 4.759

4.  Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.

Authors:  Jignesh M Doshi; Defeng Tian; Chengguo Xing
Journal:  J Med Chem       Date:  2006-12-28       Impact factor: 7.446

5.  The correlation between cancer incidence and kava consumption.

Authors:  G G Steiner
Journal:  Hawaii Med J       Date:  2000-11

6.  Evaluation of commercial kava extracts and kavalactone standards for mutagenicity and toxicity using the mammalian cell gene mutation assay in L5178Y mouse lymphoma cells.

Authors:  Paul Whittaker; Jane J Clarke; Richard H C San; Joseph M Betz; Harold E Seifried; Lowri S de Jager; Virginia C Dunkel
Journal:  Food Chem Toxicol       Date:  2007-07-31       Impact factor: 6.023

7.  Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-12       Impact factor: 2.566

8.  Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.

Authors:  Tran Dang Xuan; Masakazu Fukuta; Ao Chang Wei; Abdelnaser Abdelghany Elzaawely; Tran Dang Khanh; Shinkichi Tawata
Journal:  J Nat Med       Date:  2007-11-28       Impact factor: 2.343

9.  High dose of commercial products of kava (Piper methysticum) markedly enhanced hepatic cytochrome P450 1A1 mRNA expression with liver enlargement in rats.

Authors:  Yuko Yamazaki; Hiroko Hashida; Anna Arita; Keiko Hamaguchi; Fumio Shimura
Journal:  Food Chem Toxicol       Date:  2008-09-30       Impact factor: 6.023

10.  Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives.

Authors:  Florence Folmer; Romain Blasius; Franck Morceau; Jioji Tabudravu; Mario Dicato; Marcel Jaspars; Marc Diederich
Journal:  Biochem Pharmacol       Date:  2006-02-07       Impact factor: 5.858

View more
  12 in total

1.  Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells.

Authors:  Weiyan He; Yu Jiang; Xuebing Zhang; Yue Zhang; Honglei Ji; Nan Zhang
Journal:  Mol Cell Biochem       Date:  2014-01-04       Impact factor: 3.396

2.  Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF.

Authors:  Xiaoren Tang; Salomon Amar
Journal:  Toxicol Res (Camb)       Date:  2015-10-21       Impact factor: 3.524

3.  Kava blocks 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in association with reducing O6-methylguanine DNA adduct in A/J mice.

Authors:  Pablo Leitzman; Sreekanth C Narayanapillai; Silvia Balbo; Bo Zhou; Pramod Upadhyaya; Ahmad Ali Shaik; M Gerard O'Sullivan; Stephen S Hecht; Junxuan Lu; Chengguo Xing
Journal:  Cancer Prev Res (Phila)       Date:  2014-01

Review 4.  NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target.

Authors:  Wenshu Chen; Zi Li; Lang Bai; Yong Lin
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

5.  Neuroprotective properties of kavalactones.

Authors:  Yew-Min Tzeng; Meng-Jen Lee
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

6.  Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster).

Authors:  Amanda C Martin; Ed Johnston; Chengguo Xing; Adrian D Hegeman
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

7.  Dietary feeding of Flavokawain A, a Kava chalcone, exhibits a satisfactory safety profile and its association with enhancement of phase II enzymes in mice.

Authors:  Xuesen Li; Xia Xu; Tao Ji; Zhongbo Liu; Mai Gu; Bang H Hoang; Xiaolin Zi
Journal:  Toxicol Rep       Date:  2014

8.  Flavokawains a and B in kava, not dihydromethysticin, potentiate acetaminophen-induced hepatotoxicity in C57BL/6 mice.

Authors:  Sreekanth C Narayanapillai; Pablo Leitzman; M Gerard O'Sullivan; Chengguo Xing
Journal:  Chem Res Toxicol       Date:  2014-09-12       Impact factor: 3.739

9.  A Behavioral Survey of the Effects of Kavalactones on Caenorhabditis elegans Neuromuscular Transmission.

Authors:  Bwarenaba B Kautu; Juliana Phillips; Kellie Steele; M Shawn Mengarelli; Eric A Nord
Journal:  J Exp Neurosci       Date:  2017-06-05

10.  A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications.

Authors:  Yi Wang; Shainnel O Eans; Heather M Stacy; Sreekanth C Narayanapillai; Abhisheak Sharma; Naomi Fujioka; Linda Haddad; Jay McLaughlin; Bonnie A Avery; Chengguo Xing
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.